No Data
No Data
Trending Stocks Today | MEDIROM Healthcare Technologies Soars 97.04% Post-Market
Express News | Dermata Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN CONDITIONS (INCLUDING ACNE)"
Dermata Therapeutics Completes Enrollment in DMT310 Phase 3 STAR-1 Trial
Express News | Dermata Completes Enrollment In Phase 3 STAR-1 Trial For DMT310 Acne Treatment, Topline Results Expected March 2025, Following Successful Phase 2b Primary Endpoint Achievement
8-K: Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
10-Q: Q3 2024 Earnings Report
No Data